HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CIR Releases 2013 Draft Review Priorities For Public Comment

This article was originally published in The Rose Sheet

Executive Summary

The Cosmetic Ingredient Review maintains its current safety assessment approach, selecting ingredients with the highest reported uses for its 2013 draft priority list. The list is open for public comment, and will be finalized at the CIR Expert Panel’s September meeting.


Related Content

CIR’s Draft Ingredient List For 2015 Review Raises No Red Flags
CIR Sets 2013 Review Priorities Based On Frequency Of Use
CIR Moves To Reopen Retinol Assessment To Examine New Data
CIR To Reconsider Retinol, Triclosan, Parabens In Light Of New Data
CIR Panel Grapples With Safety Review Protocol For Nanomaterials
CIR "Evolution" Propelled By Industry Demand For More Ingredient Reviews





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts